TSX:SZLS

StageZero Life Sciences Ltd Stock Insider Trading

Toronto Stock Exchange > Healthcare > Diagnostics & Research

$0.0400

+0 (+0%)

At Close: Jun 25, 2024

StageZero Life Sciences Ltd Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 SZLS.TO shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About StageZero Life Sciences Ltd

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a ... SZLS.TO Profile

Golden Star

Ticker	Date	Change	Price
EVBG	Jun 21	0.0863%	$34.76
DDOG	Jun 21	1.33%	$117.57
BRK-A	Jun 20	0.575%	$617,249.90
EPD	Jun 18	2.90%	$28.30
USFD	Jun 18	4.33%	$53.14
INTC	Jun 18	0.359%	$30.63
UFPT	Jun 18	2.05%	$253.79
^DJI	Jun 18	0.714%	38,834.86 points
RGA	Jun 17	1.53%	$203.90
MA	Jun 17	1.68%	$448.11

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In